Roger Pomerantz - 10 Jun 2025 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)

Role
Director
Signature
/s/ Roger Pomerantz
Issuer symbol
INDP
Transactions as of
10 Jun 2025
Net transactions value
$0
Form type
4
Filing time
11 Jun 2025, 16:05:13 UTC
Previous filing
11 Apr 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pomerantz Roger Director C/O INDAPTUS THERAPEUTICS, INC., 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK /s/ Roger Pomerantz 11 Jun 2025 0001614936

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INDP Stock Option (right to buy) Award $0 +30,000 $0.000000 30,000 10 Jun 2025 Common Stock 30,000 $0.3300 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable on June 10, 2026.